These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 314765)

  • 41. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies.
    Bottazzo GF; Florin-Christensen A; Doniach D
    Lancet; 1974 Nov; 2(7892):1279-83. PubMed ID: 4139522
    [No Abstract]   [Full Text] [Related]  

  • 42. [Occurrence of various autoantibodies in autoimmune diseases].
    Lacka K; Jarczewska K; Gembicki M
    Pol Tyg Lek; 1989 Aug 7-14; 44(32-33):751-3, 770. PubMed ID: 2641801
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Diabetes mellitus type I, thyroid gland autoimmunity, thyroid gland function and HLA status].
    Kehr S; Gastauer R; Winkler G
    Monatsschr Kinderheilkd; 1985 Oct; 133(10):738-42. PubMed ID: 3906379
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nervous system disease, immunological features, and HLA phenotype in Sjögren's syndrome.
    Hietaharju A; Korpela M; Ilonen J; Frey H
    Ann Rheum Dis; 1992 Apr; 51(4):506-9. PubMed ID: 1586250
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical review 93: Autoimmune polyglandular syndrome type 1.
    Betterle C; Greggio NA; Volpato M
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1049-55. PubMed ID: 9543115
    [No Abstract]   [Full Text] [Related]  

  • 46. Influence of the HLA-DR4 antigen and iodine status on the development of autoimmune postpartum thyroiditis.
    Jansson R; Säfwenberg J; Dahlberg PA
    J Clin Endocrinol Metab; 1985 Jan; 60(1):168-73. PubMed ID: 3871091
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HLA and Graves' disease: an association with HLA-DRw3.
    Allannic H; Fauchet R; Lorcy Y; Heim J; Gueguen M; Leguerrier AM; Genetet B
    J Clin Endocrinol Metab; 1980 Oct; 51(4):863-7. PubMed ID: 6932402
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Two types of autoimmune Addison's disease associated with different polyglandular autoimmune (PGA) syndromes.
    Neufeld M; Maclaren NK; Blizzard RM
    Medicine (Baltimore); 1981 Sep; 60(5):355-62. PubMed ID: 7024719
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The genetics of Graves' disease: HLA and disease susceptibility.
    Stenszky V; Kozma L; Balázs C; Rochlitz S; Bear JC; Farid NR
    J Clin Endocrinol Metab; 1985 Oct; 61(4):735-40. PubMed ID: 3861611
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Abnormalities in thyroid function in relatives of patients with Graves' disease and Hashimoto's thyroiditis: lack of correlation with inheritance of HLA-B8.
    Chopra IJ; Solomon DH; Chopra U; Yoshihara E; Terasaki PI; Smith F
    J Clin Endocrinol Metab; 1977 Jul; 45(1):45-54. PubMed ID: 406273
    [No Abstract]   [Full Text] [Related]  

  • 51. HLA and antinuclear antibody incidence in asbestos workers.
    Matej H; Lange A; Garncarek D; Smolik R; Roszak E
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):201-5. PubMed ID: 312063
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The mechanism of spontaneous hypothyroidism in patients with Graves' disease after antithyroid drug treatment.
    Tamai H; Hirota Y; Kasagi K; Matsubayashi S; Kuma K; Iida Y; Konishi J; Okimura MC; Walter RM; Kumagai LF
    J Clin Endocrinol Metab; 1987 Apr; 64(4):718-22. PubMed ID: 2434520
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Polyendocrine failure with hypogonadism.
    Alfonso JR; Goldman MH; Kocher J
    N J Med; 1989 Jul; 86(7):531-2. PubMed ID: 2755612
    [TBL] [Abstract][Full Text] [Related]  

  • 54. HLA haplotypes in familial Graves' disease.
    Farid NR; Moens H; Larsen B; Payne R; Saltman K; Fifield F; Ingram DW
    Tissue Antigens; 1980 May; 15(5):492-500. PubMed ID: 6893771
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The HLA-A1-B8 haplotype hitchhiking with the hemochromatosis mutation: does it affect the phenotype?
    Olsson KS; Ritter B; Hansson N
    Eur J Haematol; 2007 Nov; 79(5):429-34. PubMed ID: 17924859
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Human leukocyte antigen (HLA) complex and anti-thyroidal antibodies in Graves' disease].
    Lacka K; Kordel M; Gembicki M
    Pol Tyg Lek; 1989 Feb 13-20; 44(7-8):179-81. PubMed ID: 2682567
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Update on autoimmune polyendocrine syndromes (APS).
    Betterle C; Zanchetta R
    Acta Biomed; 2003 Apr; 74(1):9-33. PubMed ID: 12817789
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prediction of remission after antithyroid drug treatment in Graves' disease.
    Young ET; Steel NR; Taylor JJ; Stephenson AM; Stratton A; Holcombe M; Kendall-Taylor P
    Q J Med; 1988 Feb; 66(250):175-89. PubMed ID: 2902655
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of primary sclerosing cholangitis with HLA-B8.
    Chapman RW; Varghese Z; Gaul R; Patel G; Kokinon N; Sherlock S
    Gut; 1983 Jan; 24(1):38-41. PubMed ID: 6600227
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Polyglandular autoimmune syndrome, type 2.
    Leor J; Levartowsky D; Sharon C
    South Med J; 1989 Mar; 82(3):374-6. PubMed ID: 2922628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.